Clinical trial

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or…

NCT00352534 · Children's Oncology Group, Other · Active, not recruiting

Key facts

NCT number NCT00352534
Title Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Official title Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Lead sponsor Children's Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Active, not recruiting
Phase Phase 3
Study type Interventional
Conditions Stage I Kidney Wilms Tumor, Stage II Kidney Wilms Tumor, Stage III Kidney Wilms Tumor
Intervention type Biological, Drug, Procedure, Radiation
Interventions 3-Dimensional Conformal Radiation Therapy, Biospecimen Collection, Chest Radiography, Computed Tomography, Dactinomycin, Doxorubicin Hydrochloride, Echocardiography Test, Magnetic Resonance Imaging, Therapeutic Conventional Surgery, Ultrasound Imaging and 1 more
Enrollment 808
Start date Nov 6, 2006
Primary completion Dec 31, 2014
Completion Sep 30, 2025
First posted Jul 14, 2006
Last update posted May 7, 2025
Countries Australia, Canada, Israel, New Zealand, Puerto Rico, Switzerland, United States

At a glance

  • 100–999 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies